Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Clin Cancer Res. 2021 Jul 20;28(1):5–12. doi: 10.1158/1078-0432.CCR-21-1193

Figure 5.

Figure 5.

Mouse model with MC38 colon cancer syngeneic tumor implanted into the subcutaneous tissue or subcutaneous and liver as depicted in Lee JC and colleagues (54). In liver and subcutaneous tumor-bearing mice, there are reduced PD-1hi/CTLA-4hi CD8+ T cells, and these tumors have reduced response to PD-1 blockade. Figure created with BioRender.com.